About
Dov Goldstein, M.D., M.B.A., is a biopharma executive and investor who has served as Chief Financial Officer of BioAge Labs since November 2021. Earlier in his career he was Managing Partner at healthcare venture firm Aisling Capital and held CFO or CEO roles at Indapta Therapeutics, Schrödinger, RIGImmune, Loxo Oncology, and Vicuron Pharmaceuticals. He also serves on public and private biotech boards including Gain Therapeutics and Coya Therapeutics.
Areas of interest
biotechbiopharmadrug developmenttherapeuticsoncologyinfectious diseasecardiometabolic diseaseaging biologylongevityhealthcare venture capitalbiotech financeboard governance